$CMGO
CMG HOLDINGS GROUP, INC.

2024 Q3 Form 10-Q Financial Statement

#000101738624000232 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $14.81K $849.7K $1.410M
YoY Change -89.87% 165.68% 859.38%
Cost Of Revenue $3.491K $665.3K $1.130M
YoY Change -87.5% 360.55% 819.76%
Gross Profit $11.31K $184.4K $279.3K
YoY Change -90.43% 5.16% 1061.94%
Gross Profit Margin 76.42% 21.7% 19.81%
Selling, General & Admin $179.0K $156.8K
YoY Change -25.41% -10.8%
% of Gross Profit 97.08% 56.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $620.00
YoY Change -32.61%
% of Gross Profit 0.22%
Operating Expenses $162.6K $179.0K $156.8K
YoY Change -41.51% -26.66% -10.8%
Operating Profit -$147.8K $5.388K $122.5K
YoY Change 12.06% -107.84% -180.74%
Interest Expense $12.46K $12.46K -$1.720K
YoY Change -13.0% -106.42%
% of Operating Profit 231.25% -1.4%
Other Income/Expense, Net $26.83K $25.87K
YoY Change -22.13% 28.52%
Pretax Income -$147.8K $31.26K $120.8K
YoY Change 12.06% -162.52% -196.69%
Income Tax
% Of Pretax Income
Net Earnings -$121.0K $31.26K $120.8K
YoY Change 24.14% -164.28% -196.69%
Net Earnings / Revenue -817.39% 3.68% 8.57%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 438.7M shares 438.7M shares 438.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $224.4K $240.6K
YoY Change 18.09% -28.85%
Cash & Equivalents $146.6K $224.4K $240.6K
Short-Term Investments
Other Short-Term Assets $100.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.887M $1.925M $1.990M
YoY Change 3.47% 2.66% 1.89%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $1.887M $1.925M $1.990M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $1.887M $1.925M $1.990M
YoY Change 3.44% 2.59% 1.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $58.51K
YoY Change 49.97%
Accrued Expenses $93.18K $80.72K $58.51K
YoY Change 59.25% 37.96% 49.99%
Deferred Revenue
YoY Change
Short-Term Debt $787.0K $787.0K
YoY Change -0.38% -1.25%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.439M $1.356M $1.378M
YoY Change 7.9% 5.26% 12.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.439M $1.356M $1.378M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.439M $1.356M $1.378M
YoY Change 7.9% 5.26% 12.85%
SHAREHOLDERS EQUITY
Retained Earnings -$14.62M -$14.50M -$14.46M
YoY Change 0.29% 0.13% 0.85%
Common Stock $438.7K $438.7K $438.7K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $448.0K $569.0K $611.4K
YoY Change
Total Liabilities & Shareholders Equity $1.887M $1.925M $1.990M
YoY Change 3.44% 2.59% 1.76%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income -$121.0K $31.26K $120.8K
YoY Change 24.14% -164.28% -196.69%
Depreciation, Depletion And Amortization $620.00
YoY Change -32.61%
Cash From Operating Activities $64.98K $138.5K
YoY Change -184.45%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$15.26K $9.750K
YoY Change -69.48% -103.77%
Cash From Investing Activities -$15.26K $9.750K
YoY Change -69.48% -103.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -10.00K
YoY Change -100.0% -104.5%
NET CHANGE
Cash From Operating Activities 64.98K 138.5K
Cash From Investing Activities -15.26K 9.750K
Cash From Financing Activities 0.000 -10.00K
Net Change In Cash 49.72K 138.2K
YoY Change -265.73% -168.95%
FREE CASH FLOW
Cash From Operating Activities $64.98K $138.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
usd
us-gaap Depreciation
Depreciation
usd
us-gaap Payments For Loans
PaymentsForLoans
usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
usd
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
usd
us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
usd
us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
dei Entity Registrant Name
EntityRegistrantName
CMG HOLDINGS GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0733770
dei Entity Address Address Line1
EntityAddressAddressLine1
2130 North Lincoln Park West 8N
dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60614
dei City Area Code
CityAreaCode
(773)
dei Local Phone Number
LocalPhoneNumber
770-3440
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
438672016 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240598 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
100000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1649189 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1989787 usd
CY2023Q4 us-gaap Assets
Assets
1989787 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
58511 usd
CY2024Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
488534 usd
CY2023Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
532914 usd
CY2024Q2 us-gaap Other Loans Payable
OtherLoansPayable
15000 usd
CY2023Q4 us-gaap Other Loans Payable
OtherLoansPayable
15000 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
712000 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
712000 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
60000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
60000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1356255 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1378425 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1356255 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1378425 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
438672016 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
438672016 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
438672016 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
438672016 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
438672 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
438672 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14630689 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14630689 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14500356 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14457999 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
569005 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
611362 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1925260 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1989787 usd
CY2024Q2 us-gaap Revenues
Revenues
849668 usd
CY2023Q2 us-gaap Revenues
Revenues
319811 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
665258 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
144450 usd
us-gaap Cost Of Revenue
CostOfRevenue
928454 usd
us-gaap Cost Of Revenue
CostOfRevenue
273943 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
184410 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
175361 usd
us-gaap Gross Profit
GrossProfit
236634 usd
us-gaap Gross Profit
GrossProfit
205482 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244111 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
327609 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
394125 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
244111 usd
us-gaap Operating Expenses
OperatingExpenses
327609 usd
us-gaap Operating Expenses
OperatingExpenses
394125 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-68750 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-90975 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-188643 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
14322 usd
us-gaap Interest Expense
InterestExpense
22210 usd
us-gaap Interest Expense
InterestExpense
24072 usd
CY2023Q2 us-gaap Interest Income Operating
InterestIncomeOperating
34450 usd
us-gaap Interest Income Operating
InterestIncomeOperating
70828 usd
us-gaap Interest Income Operating
InterestIncomeOperating
66875 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20128 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48618 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
42803 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-48622 usd
us-gaap Net Income Loss
NetIncomeLoss
-42357 usd
us-gaap Net Income Loss
NetIncomeLoss
-145840 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
611362 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-73613 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
537749 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
31256 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
569005 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
733878 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-97216 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
636662 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-48622 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
558040 usd
us-gaap Net Income Loss
NetIncomeLoss
-42357 usd
us-gaap Net Income Loss
NetIncomeLoss
-145840 usd
us-gaap Depreciation
Depreciation
1242 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
90000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
90000 usd
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-70828 usd
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-66875 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
22210 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
19500 usd
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-975 usd
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-101973 usd
us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
19122 usd
us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
12000 usd
us-gaap Payments For Loans
PaymentsForLoans
10000 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
17000 usd
us-gaap Payments To Employees
PaymentsToEmployees
34380 usd
us-gaap Payments To Employees
PaymentsToEmployees
32500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15258 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47500 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16233 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-149473 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240598 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
338157 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
224365 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188684 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80C_eus-gaap--NatureOfOperations_zTGqt8HZ3o7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><b>1 Nature of Operations and Continuance of Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 38.95pt 0 60pt; text-align: justify">Creative Management Group, Inc. was formed in Delaware on August 13, 2002 as a limited liability company named Creative Management Group, LLC. On August 7, 2007, this entity converted to a corporation. The Company is a sports, entertainment, marketing and management company providing event management implementation, sponsorships, licensing and broadcast, production and syndication.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 38.95pt 0 60pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 38.95pt 0 60pt; text-align: justify">The Company’s operating subsidiaries are XA - The Experiential Agency, Inc. - which is a sports, entertainment, marketing and management company providing event management implementation, sponsorships, licensing and broadcast, production and syndication. Its President is Alexis Laken, the daughter of the Company’s president. The other subsidiary is Lincoln Acquisition Corp. which was formed for the purpose of liquidating shares in Good Gaming, Inc. and any other investment shares which might be held by CMG at any given time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 38.95pt 0 60pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 58.5pt; background-color: white; color: #222222">The results for the three months ended June 30, 2024 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10K for the year ended December 31, 2023, filed with the Securities and Exchange Commission.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #222222"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 40.5pt 0 58.5pt; background-color: white; color: #222222">The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at June 30, 2024 and for the related periods presented.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zgrbUeBr7fF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0; text-indent: 20pt">b) Use of Estimates<i> </i></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0.05pt 0 0"> </p> <p style="font: 9.5pt/105% Times New Roman, Times, Serif; margin: 0 8.7pt 0 42.75pt; text-align: justify">The preparation of financial statements in conformity with <span style="letter-spacing: -0.15pt">generally </span>accepted accounting principles in the <span style="letter-spacing: 0.1pt">United </span>States requires management to make estimates and assumptions that affect the reported amounts of assets and li abilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions <span style="letter-spacing: 0.1pt">related </span>to the recoverability of its long-lived assets, stock-based <span style="letter-spacing: -0.05pt">compensation</span>, <span style="letter-spacing: -0.05pt">an</span>d def<span style="letter-spacing: -0.7pt">er</span>red <span style="letter-spacing: -0.05pt">incom</span>e tax asset valuation allownaces. <span style="letter-spacing: -0.05pt">Th</span>e <span style="letter-spacing: -0.05pt">Compan</span>y bases <span style="letter-spacing: -0.05pt">it</span>s <span style="letter-spacing: -0.05pt">estimate</span>s <span style="letter-spacing: -0.05pt">and </span>assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company's estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0.25pt 0 0"> </p>
us-gaap Reclassifications
Reclassifications
<p id="xdx_84B_eus-gaap--Reclassifications_zFuLedWM5Beb" style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0; text-indent: 20pt">h) Reclassifications<i> </i></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 8.3pt 0 0 43.45pt; text-align: justify">Certain prior period amounts have been reclassified to conform to current presentation. </p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 8.3pt 0 0 43.45pt; text-align: justify"> </p>
CY2019Q4 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
75000 usd
CY2019Q4 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
67500 usd
CY2019Q4 us-gaap Loans Receivable Basis Spread On Variable Rate
LoansReceivableBasisSpreadOnVariableRate
0.12 pure
CY2020 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
32500 usd
CY2020 cmgo Convert Loan Receivable To Amount
ConvertLoanReceivableToAmount
1000 usd
CY2020Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
50000 usd
us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
999201 usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
60000 usd
CY2020 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
40000000 shares
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0035
cmgo Term Of Warrant
TermOfWarrant
P5Y
CY2022 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
500000 usd
CY2022 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2022-11-23
CY2023Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
6 pure
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0165
CY2022 us-gaap Proceeds From Loans
ProceedsFromLoans
222000 usd
us-gaap Payments For Loans
PaymentsForLoans
10000 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
712000 usd
CY2017 us-gaap Proceeds From Loans
ProceedsFromLoans
150000 usd
CY2021 us-gaap Payments For Loans
PaymentsForLoans
90000 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
60000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
14579363 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
10169 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
25729 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-10169 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-25729 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
14500356 usd
CY2024Q2 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
14500356 usd
us-gaap Revenues
Revenues
1165088 usd
cmgo Segment Cost Of Revenue
SegmentCostOfRevenue
928454 usd
cmgo Segment Gross Profit
SegmentGrossProfit
236634 usd
us-gaap Costs And Expenses
CostsAndExpenses
327609 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-90976 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
48618 usd
cmgo Net Income Loss Segment Reporting
NetIncomeLossSegmentReporting
-42357 usd
us-gaap Revenues
Revenues
479425 usd
cmgo Segment Cost Of Revenue
SegmentCostOfRevenue
278943 usd
cmgo Segment Gross Profit
SegmentGrossProfit
205482 usd
us-gaap Costs And Expenses
CostsAndExpenses
394124 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-188642 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
42803 usd
cmgo Net Income Loss Segment Reporting
NetIncomeLossSegmentReporting
-147830 usd
us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0 pure
CY2024Q2 us-gaap Loans Payable
LoansPayable
15000 usd
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
40000000 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0155
cmgo Term Of Warrant
TermOfWarrant
P5Y
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0035
cmgo Term Of Warrant
TermOfWarrant
P5Y
CY2024Q3 cmgo Profit Sharing
ProfitSharing
0.070 pure
CY2024 cmgo Profit
Profit
3600000 usd
CY2025 cmgo Profit
Profit
4800000 usd

Files In Submission

Name View Source Status
0001017386-24-000232-index-headers.html Edgar Link pending
0001017386-24-000232-index.html Edgar Link pending
0001017386-24-000232.txt Edgar Link pending
0001017386-24-000232-xbrl.zip Edgar Link pending
cmgo-20240630.xsd Edgar Link pending
cmgo_2024jun30-10q.htm Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cmgo-20240630_def.xml Edgar Link unprocessable
cmgo-20240630_lab.xml Edgar Link unprocessable
cmgo-20240630_pre.xml Edgar Link unprocessable
cmgo_2024jun30-10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
cmgo-20240630_cal.xml Edgar Link unprocessable